| RS2100414767 |
NFIA
|
Health Risk |
Likely pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS2100415350 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100415367 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100417039 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100417374 |
ACADM
|
Health Risk |
Conflicting classifications of pathogenicity |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100417454 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100417476 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100417619 |
ACADM
|
Health Risk |
Pathogenic/Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100417620 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100417735 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100417752 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100419143 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100419408 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2100420854 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100421533 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100421716 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100421727 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100422532 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100422652 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100423250 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100423312 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100423836 |
MTOR
|
Health Risk |
Likely pathogenic |
— |
| RS2100423871 |
MTOR
|
Health Risk |
Likely pathogenic |
Overgrowth syndrome, Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
| RS2100428321 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100428385 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100428583 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100428812 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100429011 |
PEX10
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100429148 |
PEX10
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, complementation group 7 |
| RS2100429450 |
PEX10
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2100433281 |
MTOR
|
Health Risk |
Likely pathogenic |
— |
| RS2100440701 |
ALG6
|
Health Risk |
Pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS2100451989 |
GNB1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2100452011 |
GNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2100452147 |
WLS
|
Health Risk |
Pathogenic |
WLS syndrome, Zaki syndrome |
| RS2100452908 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100452915 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100452990 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100453109 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100453278 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100453287 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100453612 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100453846 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS2100466824 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Nephronophthisis 4 |
| RS2100471616 |
NPHP4
|
Health Risk |
Pathogenic |
— |
| RS2100477650 |
MTOR
|
Health Risk |
Likely pathogenic |
Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes |
| RS2100479399 |
GNB1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2100485780 |
NFIA
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2100494177 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100495241 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS2100499107 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100499494 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100506903 |
MTHFR
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2100507511 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100513927 |
MSH4
|
Health Risk |
Pathogenic |
Spermatogenic failure 2, Spermatogenic failure 2 |
| RS2100519683 |
MTOR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2100520890 |
NFIA
|
Health Risk |
Likely pathogenic |
Chromosome 1p32-p31 deletion syndrome, Brain malformations with or without urinary tract defects |
| RS2100522053 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2100523280 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100524602 |
MTHFR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2100527601 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100527918 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100528352 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100546091 |
GNB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 42 |
| RS2100546220 |
GNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 42 |
| RS2100562061 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100566800 |
MTOR
|
Health Risk |
Likely pathogenic |
Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes, Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes |
| RS2100566841 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100568604 |
MTHFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS2100570734 |
MSH4
|
Health Risk |
Pathogenic |
Spermatogenic failure 2, Spermatogenic failure 2 |
| RS2100577466 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS2100581757 |
MSH4
|
Health Risk |
Pathogenic |
Spermatogenic failure 2, Spermatogenic failure 2 |
| RS2100593635 |
ALDH4A1
|
Health Risk |
Pathogenic |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS2100594030 |
PIGK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures |
| RS2100609915 |
MTOR
|
Health Risk |
Likely pathogenic |
Isolated focal cortical dysplasia type II, Isolated focal cortical dysplasia type II |
| RS2100620614 |
NPHP4
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Senior-Loken syndrome 4 |
| RS2100635216 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2100635414 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2100658801 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2100658808 |
MYSM1
|
Health Risk |
Pathogenic |
— |
| RS2100662912 |
PRDM16
|
Health Risk |
Pathogenic |
Left ventricular noncompaction cardiomyopathy, Left ventricular noncompaction cardiomyopathy |
| RS2100664124 |
PRDM16
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction 8, Left ventricular noncompaction 8 |
| RS2100666336 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2100672432 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2100676852 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2100676956 |
RPL5
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2100676969 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS2100677043 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2100677045 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS2100677960 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Harel-Yoon syndrome, Inborn genetic diseases |
| RS2100678099 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2100682020 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2100685034 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2100685045 |
RPL5
|
Health Risk |
Likely pathogenic |
— |
| RS2100685111 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 6 |
| RS2100688383 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2100688414 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS2100689699 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2100695149 |
TMEM240
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 21, Spinocerebellar ataxia type 21 |
| RS2100697037 |
RPL5
|
Health Risk |
Likely pathogenic |
— |